FindTrial
Sign In

Paclitaxel for Injection

DRUG5 trials

Sponsors

Bio-Thera Solutions, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.

Conditions

Advanced Solid TumorCervical CancerMetastatic Pancreatic Ductal AdenocarcinomaPD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast CancerSolid Tumor

Phase 1

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
RecruitingNCT07229586
Shanghai Hengrui Pharmaceutical Co., Ltd.Solid Tumor
Start: 2025-12-02End: 2027-12-31Target: 100Updated: 2025-12-19
A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors
Not yet recruitingNCT07298772
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Advanced Solid Tumor
Start: 2025-12-31End: 2028-01-31Target: 198Updated: 2025-12-23

Phase 2

BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
RecruitingNCT06123884
Bio-Thera SolutionsCervical Cancer
Start: 2023-12-13End: 2027-01-31Target: 526Updated: 2025-02-10

Phase 3

A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
RecruitingNCT07111832
Suzhou Suncadia Biopharmaceuticals Co., Ltd.PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Start: 2025-08-20End: 2028-12-31Target: 400Updated: 2025-12-18
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
RecruitingNCT07165951
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Metastatic Pancreatic Ductal Adenocarcinoma
Start: 2025-12-02End: 2028-12-31Target: 566Updated: 2025-12-24

Related Papers

Primary efficacy and safety results of BAT1308, a PD-1 inhibitor, + chemotherapy ± bevacizumab in phase 2 trial for persistent, recurrent, or metastatic cervical cancer.
Journal of Clinical Oncology2025-05-28